<DOC>
	<DOCNO>NCT01355367</DOCNO>
	<brief_summary>This clinical study evaluate safety efficacy long term administration oral BAYA1040 CR 80 mg/day ( 40 mg twice daily ) patient essential hypertension test drug tolerable 8 week double blind treatment phase Study 13176 .</brief_summary>
	<brief_title>High Dose BAYA1040 CR : Long Term Extension Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<criteria>Patients complete 8 week double blind treatment phase Study 13176 test drug tolerable Patients expect difficulty continuous 1 year follow</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>BAYA1040 CR</keyword>
	<keyword>Nifedipine</keyword>
	<keyword>Essential hypertension</keyword>
	<keyword>Japanese Patients</keyword>
	<keyword>Phase III</keyword>
	<keyword>Extension study</keyword>
</DOC>